Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/1999
09/16/1999WO1999045918A1 Methods and compositions for delivery of taxanes
09/16/1999WO1999045904A1 Delivery system to modulate immune response
09/16/1999WO1999045903A1 Colonic delivery of protein or peptide compositions
09/16/1999WO1999045902A1 Nicotine inhaler
09/16/1999WO1999045887A2 Monolithic tablet for controlled drug release
09/16/1999WO1999045869A1 Use of corneal hardening agents in enzyme orthokeratology
09/16/1999WO1999045779A1 Novel compositions of eprosartan
09/16/1999WO1999045776A1 Treatment of respiratory disease and otitis media
09/16/1999WO1999045771A1 Tissue paper having antimicrobial skin lotion
09/16/1999WO1999036059A3 Microcapsules; process for preparing microcapsules containing a biologically active compound and liquid solution
09/16/1999WO1999033500A3 Methods, systems, and kits for intravascular nucleic acid delivery
09/16/1999WO1999032082A3 Pharmaceutical compositions
09/16/1999WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease
09/16/1999DE19811951A1 Composition useful for delayed release of active agents
09/16/1999DE19811167A1 Tablet/lozenge useful for duration athletes typically includes maltodextrin, vitamins, magnesium citrate and powdered orange peel
09/16/1999DE19810965A1 Nanoparticles comprising polyelectrolyte complex of polycation, polyanion and biologically active agent, especially useful for controlled drug release on oral administration
09/16/1999DE19810951A1 Textile material useful for transdermal delivery of a drug which is incorporated into cyclodextrin fixed to the material
09/16/1999DE19810655A1 Pharmaceutical composition containing cyclosporin A suitable for topical administration for treating disorders of skin, mucosa and eyes
09/16/1999CA2323212A1 Process of making an aqueous calcium carbonate suspension
09/16/1999CA2323199A1 Use of corneal hardening agents in enzyme orthokeratology
09/16/1999CA2323177A1 Composition
09/16/1999CA2323062A1 Colonic delivery of protein or peptide compositions
09/16/1999CA2323016A1 Multicomponent complex for use with a substrate
09/16/1999CA2322839A1 Peptide compositions and formulations and use of same
09/16/1999CA2322472A1 Delivery system to modulate immune response
09/16/1999CA2318782A1 Polyvinyl alcohol compositions
09/16/1999CA2288240A1 Methods and compositions for delivery of taxanes
09/15/1999EP0941241A1 $i(BORDETELLA) STRAIN EXPRESSING THE FHA HYBRID, LIPOSOMES AND VACCINES
09/15/1999EP0941121A2 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
09/15/1999EP0941116A2 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
09/15/1999EP0941099A1 Method of treating bronchitis with uridine triphosphates and related compounds
09/15/1999EP0941097A1 Use of mixtures of active substances for the production of hypocholesteremic agents
09/15/1999EP0941095A1 Improved pharmaceutical compositions
09/15/1999EP0941094A1 Process for manufacturing ophthalmic suspensions
09/15/1999EP0941090A1 Pharmaceutical compositions containing n-sulphonyl indolin derivatives
09/15/1999EP0941089A2 Compositions and methods for treating or preventing inflammatory diseases
09/15/1999EP0941087A1 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections
09/15/1999EP0941085A2 Formulation for electrically assisted delivery of lidocaine and epinephrine
09/15/1999EP0941083A1 Pharmaceutical compositions containing 3-iodo-1,2-propanediol having mucolytic activity
09/15/1999EP0941079A1 Bioceramic compositions
09/15/1999EP0941078A1 Method and apparatus for the coating of substrates for pharmaceutical use
09/15/1999EP0941077A1 Method for producing a therapeutic system in the form of plaster
09/15/1999EP0941076A1 Sealing medium for composite packaging materials
09/15/1999EP0941075A1 Rapidly releasing and taste-masking pharmaceutical dosage form
09/15/1999EP0941074A1 Delayed delivery system for acid-sensitive drugs
09/15/1999EP0941073A1 Product
09/15/1999EP0941072A1 Method and apparatus for the coating of substrates for pharmaceutical use
09/15/1999EP0941071A1 Gastric-retentive, oral drug dosage forms for the controlled-release of sparingly soluble drugs and insoluble matter
09/15/1999EP0941070A2 Lozenge for the modified releasing of active substances in the gastrointestinal tract
09/15/1999EP0941069A1 COMPACT MEMBER COMPRISING A PLURALITY OF POROUS CELLULOSE MATRICES, (PCMs), METHOD OF MANUFACTURING AND USE THEREOF
09/15/1999EP0941068A1 Process for the preparation of a controlled release system
09/15/1999EP0941067A2 Stable glassy state powder formulations
09/15/1999EP0941066A1 Cationic lipid-nucleic acid complexes
09/15/1999EP0941065A1 Ionophore-mediated liposome loading of weakly basic drug
09/15/1999EP0941064A1 PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED RELEASE OF beta -LACTAM ANTIBIOTICS
09/15/1999EP0941063A1 Transdermal compositions containing levosimendan
09/15/1999EP0941039A1 Transdermal administration of ment
09/15/1999EP0850065B1 Transdermal therapeutical system for silatran compounds
09/15/1999EP0836538B1 Waste management process for transdermal active substances
09/15/1999EP0804239B1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
09/15/1999EP0759739A4 Improvements in dental floss
09/15/1999EP0748383B1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/15/1999EP0683666B1 Water based beverages
09/15/1999EP0652752B1 Water-dispersible tablets
09/15/1999EP0644746B1 The use of glycerin in moderating transdermal drug delivery
09/15/1999CN2338005Y Edible and health-care medicine pills
09/15/1999CN1228712A Aqueous-based pharmaceutical composition
09/15/1999CN1228710A Pharmaceutical composition containing lornoxicam and disodic salt of EDTA
09/15/1999CN1228708A Peptide-containing drug compositions for oral administration
09/15/1999CN1228707A Titanium slow-release composition
09/15/1999CN1228706A Hydrogenous medicament
09/15/1999CN1228702A Transdermal therapeutical approach involving combination of active substances containing oestriol
09/15/1999CN1228700A Tablet with controlled release of alfuzosine chlorydrate
09/15/1999CN1228699A Antifungal composition with enhanced bioavailability
09/15/1999CN1228693A Oral composition comprising triazole antifungal compound
09/15/1999CN1228692A Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
09/15/1999CN1228691A Dosage form for providing ascending dose of drug
09/15/1999CN1228339A Sponge material capable of promoting spinal cord tissue wound healing, its preparing method and use
09/15/1999CN1228332A Drug for curing migraine and its preparing method
09/15/1999CN1228324A Traditional Chinese medicinal plaster-Baiqigao for curing rheumatism, sciatica and traumatic injury
09/15/1999CN1228323A Fenghan Dieda plaster for curing traumatic injury and its preparing method
09/15/1999CN1228317A Traditional Chinese medicine-Jiangtangwan pill for curing diabets mellitus
09/15/1999CN1228312A Externally used Chinese medicinal pill for curing tinnitus and deaf, its preparing method and use
09/15/1999CN1228310A Xiaoaisan powder for curing cancer
09/15/1999CN1228302A Preparation of ampicillin skin test liquid and its usage
09/15/1999CN1045083C Lifibrol antilipemic agent and its use
09/14/1999US5952398 Multi-step mixing, emulification, photopolymerization to produce a peel adhesion adhesive; for use in biomedical articles, such as biomedical electrodes, medical skin coverings, and pharmaceutical drug delivery devices
09/14/1999US5952395 Gelled ultrafine oil-in-water emulsion stabilized with a crosslinked poly(2-acrylamido-2-methylpropanesulfonic acid) polymer neutralized to at least 90% process of preparation and applications
09/14/1999US5952383 Liquid support oil, suspending agent, homogenizing agent, surfactant and expedients; antiinflammatory agents
09/14/1999US5952356 Treating diabetes in a mammal with an active material and a glucosidase inhibitor
09/14/1999US5952318 Treatment of HIV positive patients
09/14/1999US5952312 NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration
09/14/1999US5952303 A freeze-dryed artificial pulmonary surfactant comprising kl4 polypeptide and di- and monopalmitoylphosphatidylcholine; storage stability; nonhydrolyzing; reduced viscosity; homogeneity
09/14/1999US5952300 Antifungal compositions
09/14/1999US5952232 Expandible microparticle intracellular delivery system
09/14/1999US5952226 Hypoxia responsive EPO producing cells
09/14/1999US5952220 Preparing a dilute viral suspension in an aqueous solution which is then nebulised with gas pressure or ultrasound; treatment of respiratory diseases, asthma, lung cancer, cystic fibrosis
09/14/1999US5952043 Heating emulsion so the lipid phase is fluid, cooling to solidify on carrier; external lipid phase of the emulsion is sufficiently brittle that it ruptures during low shear to release dispersed internal polar phase; perianal cleaning
09/14/1999US5952021 Stabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluids
09/14/1999US5952008 Desolventizing a solution with a pharmaceutically active polypeptide and an adjuvant for enhancing the systemic absorption of the peptide dissolved therein; pulverizing the dry solid, optionally agglomerating, loading into inhaler